PMID- 25619541
OWN - NLM
STAT- MEDLINE
DCOM- 20160104
LR  - 20221207
IS  - 1875-6417 (Electronic)
IS  - 1573-3998 (Linking)
VI  - 11
IP  - 2
DP  - 2015
TI  - Predictive factors of follow-up non-attendance and mortality among adults with 
      type 2 diabetes mellitus- an analysis of the Malaysian diabetes registry 2009.
PG  - 122-31
AB  - This study examined the factors associated with follow-up non-attendance (FUNA) 
      and mortality among the adult patients with type 2 diabetes mellitus (T2DM). Data 
      on 57780 T2DM patients from the 2009 diabetes registry were analyzed using 
      multinomial logistic mixed model. Out of 57780 patients, 3140 (5.4%) were lost to 
      follow-up and 203 (0.4%) patients had died. Compared with patients who were under 
      active follow-up, men (OR 1.37), neither on insulin (OR 1.72), nor on 
      antiplatelet agents (OR 1.47), having higher HbA1c (OR 1.15), higher LDL-C (OR 
      1.18) and complications (OR 1.33) were associated with FUNA. Older age (OR 1.09) 
      and higher LDL-C (OR 2.27) have higher mortality. Across the four different 
      health facilities, medication use (insulin and anti-platelet agents) to achieve 
      better disease control in the younger age when diabetes complication is absent 
      would not cause FUNA and might reduce mortality.
FAU - Chew, Boon-How
AU  - Chew BH
AD  - Department of Family Medicine, Faculty of Medicine & Health Sciences, Universiti 
      Putra Malaysia, 43400 Serdang, Selangor, Malaysia. chewboonhow@gmail.com.
FAU - Lee, Ping-Yein
AU  - Lee PY
FAU - Shariff-Ghazali, Sazlina
AU  - Shariff-Ghazali S
FAU - Cheong, Ai-Theng
AU  - Cheong AT
FAU - Ismail, Mastura
AU  - Ismail M
FAU - Taher, Sri-Wahyu
AU  - Taher SW
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
PL  - United Arab Emirates
TA  - Curr Diabetes Rev
JT  - Current diabetes reviews
JID - 101253260
RN  - 0 (Blood Glucose)
RN  - 0 (Cholesterol, LDL)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
RN  - 0 (Platelet Aggregation Inhibitors)
SB  - IM
MH  - Aged
MH  - Blood Glucose/analysis
MH  - Cholesterol, LDL/blood
MH  - Diabetes Complications/*drug therapy
MH  - Diabetes Mellitus, Type 2/*drug therapy
MH  - Female
MH  - Follow-Up Studies
MH  - Glycated Hemoglobin/analysis
MH  - Humans
MH  - Hypoglycemic Agents/*therapeutic use
MH  - Insulin/*therapeutic use
MH  - Logistic Models
MH  - Lost to Follow-Up
MH  - Malaysia
MH  - Male
MH  - Middle Aged
MH  - *Mortality
MH  - Platelet Aggregation Inhibitors/*therapeutic use
MH  - Prognosis
MH  - Risk Factors
EDAT- 2015/01/27 06:00
MHDA- 2016/01/05 06:00
CRDT- 2015/01/27 06:00
PHST- 2014/10/24 00:00 [received]
PHST- 2015/01/10 00:00 [revised]
PHST- 2015/01/12 00:00 [accepted]
PHST- 2015/01/27 06:00 [entrez]
PHST- 2015/01/27 06:00 [pubmed]
PHST- 2016/01/05 06:00 [medline]
AID - CDR-EPUB-64561 [pii]
AID - 10.2174/1573399811666150115105206 [doi]
PST - ppublish
SO  - Curr Diabetes Rev. 2015;11(2):122-31. doi: 10.2174/1573399811666150115105206.